Gregory Katz is Chaired Professor of Innovation & Value in Health at the University of Paris School of Medicine. He is founder and Executive Director of Consortium VBHC France, a nonprofit organization dedicated to accelerating the emergence of patient-reported outcome registries to enable medical teams to evaluate, improve and incentivize their results. His research focuses on innovation management in life sciences & value-based health care. As lead author, he publishes scientific articles in academic journals such as PLOS, J Bone & Joint Surgery, Transfusion, Yale J of Health Policy. From 2007 to 2015, he was Director of Clinical Research at Ramsay Générale de Santé - a European leader in private hospitalization - and Director of its non-profit Foundation. From 2015 to 2019, he was Director of Research & Innovation at Elsan, a leading group of private hospitals in France. From 2003-2005, he was Visiting Professor at INSEAD in Fontainebleau & Singapore. From 2004 to 2015, he was Chaired Professor of Therapeutic Innovation and Co-director of the Institute for Health Economics & Management at ESSEC Business School (Paris-Singapore). His pro bono activities include Vice-President of the Eurocord Association, an international platform for clinical research on cord blood stem cell transplantation, from 2004 to 2008. He was a board member of the European School of Surgery (2009-2012), Chairman of the Scientific Board of GlaxoSmithKline Vaccines Global Innovation Fund (2012-2015), and Chairman of the Think Tank Digital Leaders in Health (2018). He is the recipient of several awards, including the San Benedetto International Prize for his achievements in bioethics and humanism (2009) and the Special Jury Award from the French Fédération de l’Hospitalisation Privée (2012). In 2015, he was invited as eminent scholar for the Grand Rounds Lecture at the UCLA Fielding School of Public Health.
Peter Pitts is President of the Center for Medicine in the Public Interest. He is a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration. Pitts is a member of the Council for International Organizations of Medical Sciences (CIOMS is a NGO established jointly by WHO and UNESCO in 1949) Expert Working Group to help advance patient involvement in the development and safe use of medicines. He is the lead author of many peer reviewed publications including the Lancet and Nature Biotechnology. He is an Associate Editor of Therapeutic Innovation & Regulatory Science (official DIA journal), a member of the External Advisory Board, IMS Institute for Healthcare Informatics in Asia, Executive Advisory Board, the Galien Foundation, Editorial Advisory Board, Food and Drug Policy Forum, Advisory Board, Journal of Commercial Biotechnology and the Editorial Advisory Board, The Patient Magazine. Pitts lives in New York City.
Only students from University of Paris School of Medicine are eligible to apply. The Chair welcomes medical students (years 4, 5, 6 and residents), PharmD and PhD students, master students, and students from university exchange programs (Erasmus, etc.). The application process involves the following steps:
+33 1 53 10 47 03
University of Paris School of Medicine
Chair of Innovation & Value in Health
15, rue de l’Ecole de Médecine 75006 Paris, France